Hypertension

New research from a hospital in Wuhan has found no difference in hypertension patients whether or not they were taking ACEi/ARBs on admission.

In healthy people, it's normal for blood pressure to drop during the night.  But in hypertensive patients, nighttime blood pressure sometimes doesn't drop, or even increases.  A new study published online in the journal Neurology, shows that those individuals may be more likely to have small areas in the brain that appear damaged from vascular disease and associated memory problems.

New research suggests the presence of a maternal hypertensive disorder predicts increased risk of childhood mental disorder, regardless of mental disorder status of the parents.

Discussion the debate around use of ACE inhibitors and ARBS as well as other common questions the ESC has been fielding during the ongoing outbreak.

New research from a feasibility trial suggests new technology could help patients achieve BP control at a similar rate as regular visits.

The Penn Medicine trial is currently enrolling and will evaluate effects across a multitude of outcomes.

The tailored approach for delivering lifestyle changes virtually to patients who are obese with hypertension shows positive health benefits.

Investigators from Saint Louis University discuss a new comparison of 2 drug classes that could reduce the risk of adverse cardiovascular events.

A new study analyzing at-home blood pressure devices available for purchase online has found most are not validated—bringing their accuracy into question.

A new perspective from federal and institutional experts explains the cause of disease severity and mortality in older, cardiovascular-risk patients.

Results of the SPYRAL-HTN OFF MED indicate renal denervation could prove useful for lowering SBP in patients with untreated hypertension.

What effect may professional athletes receiving asymptomatic tests have on the public perception of the coronavirus?

A study of 416 hospitalized patients indicates 19.7% suffered cardiac injury, which was also associated with increased ventilation and mortality.

A new review from investigators at Columbia University details topics from common comorbidities to potential treatments.

A discussion with a Brigham and Women's Hospital cardiologist on the research of the add-on cardiometabolic drug class.

The document, which includes 11 clinical competencies for NPs and PAs, is the first of its kind from the American College of Cardiology.

Manesh Patel, MD, of Duke University School of Medicine, discusses what we know about COVID-19 and its impact on cardiovascular health.

Telehealth tools can identify someone whose symptoms are worsening and connect them to a medical professional.

Physicians and patients should continue treatment with their usual anti-hypertensive or diabetes management therapy, says the European Society of Cardiology (ESC).  There is no evidence that ACEi or ARBs, drugs which upregulate Angiotensin Converting Enzyme (ACE), increase the risk of contracting COVID-19, the society said in a statement published March 13.

A new analysis has found that low blood pressure in older, frail adults could increase mortality risk as much as 63%.

New data from a study of 30 patients found specific characteristics of gut microbiota could predict the presence of pulmonary hypertension with greater than 80% accuracy.

New data indicates a combination of 3 natural extracts added to standard therapy could provide benefits in patients with uncontrolled hypertension.

A new study from the Columbia University Irving Medical Center found another diuretic appeared to have less serious side effects than the guideline-recommended chlorthalidone.

A new analysis of more than 15,000 Europeans found bariatric surgery could reduce all-cause mortality and heart failure.

Compared with other antihypertensive medications, amlodipine was found to reduce risk of gout in older patients.

A new study is warning a common practice when it comes to recording blood pressure could be ignoring a potential warning sign for risk later in life.

Blood pressure irregularities start early for women and progress more rapidly than in men, eventually leading to cardiovascular disease later in life, researchers report in JAMA Cardiology.

Deceased donor kidneys could offer a solution to a major kidney shortage in the US.

An expecting mother's use of antihypertensive medication may affect their risk of having a preterm birth, new findings show.

Findings of a systematic review showed that traffic-related air pollution can lead to hypertensive disorders and cardiovascular events for pregnant women.